CTLA4 and type 1 diabetes mellitus: Identifying T1D patients carrying at-risk alleles in CTLA-4 or FOXO-3 may enable targeted interventions such as optimized vitamin D supplementation, tailored probiotic regimens, stress management strategies, and lifestyle modifications to reduce AITD or MASLD risk.